79803-73-9,
MOPSO sodium salt,
Sodium 2-hydroxy-3-morpholinopropane-1-sulfonate,
3-Morpholino-2-hydroxypropanesulfonic acid sodium salt,
3-(N-Morpholinyl)-2-hydroxypropanesulfonic acid sodium salt,
MFCD00070007,
sodium 2-hydroxy-3-(morpholin-4-yl)propane-1-sulfonate,
C7H14NNaO5S,
SCHEMBL2944246,
CTK8B8185,
DTXSID70635489,
ZX-AFC003201,
KS-00000XV3,
ANW-59587,
GB3228,
AKOS015902366,
AKOS016003854,
RTR-025311,
AC-24633,
AK-47311,
AN-36502,
MOPSO sodium salt, >=99% (titration),
MOPSO, 0.2M buffer solution, pH 6.0,
MOPSO, 0.2M buffer solution, pH 7.5,
AX8140363,
FT-0660594,
ST24031624,
ST51037354,
C-53144,
sodium 2-hydroxy-3-morpholino-propane-1-sulfonate,
(3-(N-Morpholino)-2-hydroxy-propane sulfonic acid,
MOPSO sodium salt, Vetec(TM) reagent grade, 98%,
I14-19796,
2-hydroxy-3-morpholin-4-ylpropanesulfonic acid, sodium salt,
3-Morpholino-2-hydroxypropane-1-sulfonic acid sodium salt,
potassium 2-hydroxy-3-(morpholin-4-yl)propane-1-sulfonate,
MOPSO sodium salt, BioXtra, pH 10-12 (1 M in H2O), >=99% (titration),
MOPSO, sodium salt, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production, suitable for cell culture,
Mopso,
CID11172661,
Sodium 2-hydroxy-3-morpholin-4-yl-propane-1-sulfonate,